Filing Details
- Accession Number:
- 0001127602-24-012414
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-04-03 20:24:27
- Reporting Period:
- 2024-04-02
- Accepted Time:
- 2024-04-03 20:24:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875045 | Biogen Inc. | BIIB | Biological Products, (No Disgnostic Substances) (2836) | 330112644 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1769608 | Priya Singhal | 225 Binney Cambridge MA 02142 | Head Of Development | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-04-02 | 93 | $213.09 | 4,886 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- 1. Includes 93.3846 shares acquired under the Biogen Inc. employee stock purchase plan on 3/28/2024.
Billionaire Hedge Funds
